FDA Approves First Generic Divalproex Sodium To Treat Seizures, Migraine Headaches And Bipolar Disorder
Filed under Articles, General, Migraine, Migraine Research – August 4th, 2008
The U.S. Food and Drug Administration approved the first generic versions of Depakote delayed-release tablets (divalproex sodium). Depakote is approved by the FDA for the treatment of seizures, bipolar disorder and migraine headaches.
“Generic drugs undergo a rigorous scientific review to ensure that they will provide the patient with the same amount of high quality, safe [...]

